Cao, Y., Shi, .F. , Li, Y. , Wei, X. , Yi, .H. and Han, S. 2024. Cost-effectiveness analysis of the combination of low-dose nivolumab with triple metronomic chemotherapy for advanced head and neck squamous cell carcinoma in China. Health Decision. 2, S1 (Jul. 2024). DOI:https://doi.org/10.54844/hd.2024.0008.